Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending July 2014. The document serves as a notification of a transaction involving a person discharging managerial responsibility, specifically regarding a change in share interests.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to a specific director transaction notification and does not contain financial performance data.
Material Changes
No material changes to the company's financial position or operations are reported in this filing. The document details a single transaction: the purchase of Ordinary Shares by Mr. S M Bicknell on July 7, 2014.
Guidance, Outlook, and Risks
The filing contains no management commentary, guidance, outlook, or discussion of risks and contingencies. The transaction was executed at a price of 1582.00 pence per Ordinary Share following the re-investment of dividends on shares held within an Individual Savings Account (ISA).
Important Facts for Investors
- Transaction Type: Purchase of Ordinary Shares by a person discharging managerial responsibility (Mr. S M Bicknell).
- Transaction Date: July 7, 2014.
- Share Price: 1582.00 pence per share.
- Source of Funds: Re-investment of dividends from shares held within an ISA.
- Regulatory Basis: Notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).